James H. Stanker - Aug 5, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Financial Officer
Signature
/s/ James H. Stanker by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Aug 5, 2022
Transactions value $
-$7,805
Form type
4
Date filed
8/9/2022, 04:28 PM
Previous filing
Jul 5, 2022
Next filing
Oct 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +7.6K +17.23% 51.7K Aug 5, 2022 Direct F1
transaction PCSA Common Stock Tax liability -$7.8K -2.46K -4.76% $3.17 49.3K Aug 5, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.